Category: Washington, D.C.
-
Patient exodus and slower sales cast clouds over D.C. market
D.C. patient expirations outpace new registrations as medical sales continue decline Cultivation and manufacturing revenue in D.C.’s medical cannabis program continue to be below 2023, but they are growing slowly after hitting a low last fall. However, retail sales fell to their lowest point in four years last month, according to ABCA monthly revenue report.…
-
D.C. medical cannabis sales close out 2023 with six-month high
Six-month high in D.C. medical cannabis sales While overall sales haven’t reached pre-Maryland adult-use launch levels, D.C.’s medical cannabis market showed signs of stability in December 2023. Total sales reached nearly $3 million, marking the highest monthly figure since Maryland’s recreational market opened in July. Interestingly, patients benefiting from reduced licensing fees contributed over $300,000,…